Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Christelle Ratignier"'
Autor:
Laëtitia Belgodère, Joseph Emmerich, Nicolas Albin, Trystan Bacon, Pascale Daynes, Stéphane Vignot, Thierry Vial, Guillaume Renaud, Carole Le Saulnier, Corine Maillard-Couvreur, Mélanie Cachet, Marie-Laure Veyries, Rym Youdarene, Wahiba Oualikene-Gonin, Christelle Ratignier-Carbonneil, Patrick Maison
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
Shortages of drugs and medical devices have tended to increase in France and worldwide, with consequences for patients and healthcare professionals. Preventing shortages of health products has become a priority for regulatory authorities, including t
Externí odkaz:
https://doaj.org/article/a9ff1c470a374598b3b60fd4f8e1cb47
Autor:
Stéphane Vignot, Alban Dhanani, Isabelle Sainte-Marie, Laure de Ligniville Lajavardi, Gwennaelle Even, Muriel Echemann, Nina Hulin, Claire Ménoret, Patrick Maison, Christelle Ratignier-Carbonneil
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The COVID-19 pandemic was immediately marked by strong clinical research activity. The French national competent authority presents the data on request for authorization during the first 2 years of COVID-19 pandemic to inform discussions on future cl
Externí odkaz:
https://doaj.org/article/299848bcc9a742aa879c252272a94872
Autor:
Patrick Maison, Mahmoud Zureik, Virginie Hivert, Jesper Kjaer, Roman Hossein Khonsari, Gianluca Trifirõ, Christelle Ratignier-Carbonneil
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/38f89f9166dc4d55b8e33addacd41222
Autor:
Stéphane Vignot, Pascale Daynes, Trystan Bacon, Thierry Vial, Olivier Montagne, Nicolas Albin, Joseph Emmerich, Christelle Ratignier-Carbonneil, Dominique Martin, Patrick Maison
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/82fa6c74d4e249f183675fa4e43ab583
Publikováno v:
BMJ Open, Vol 10, Iss 3 (2020)
ObjectivesThe aim was to provide figures for drug shortages in France and describe their characteristics, causes and trends between 2012 and 2018.MethodsData from the national reporting system from the Agency of Medicine and Health Product Safety (AN
Externí odkaz:
https://doaj.org/article/8bb38f2813994d4787722a6ecf9927d7
Autor:
Stéphane Vignot, Gaelle Guyader, Valérie Salomon, Philippe Vella, Isabelle Yoldjian, Patrick Maison, Christelle Ratignier-Carbonneil
Publikováno v:
Reviews on Recent Clinical Trials. 18
The implementation of the new European Clinical Trial Regulation on 31 January 2022, is a major step to promote clinical research in Europe. The French National Agency for Medicines and Health Products Safety (ANSM) proposes to share some key aspects
Autor:
Jean-François Bergmann, Cécile Rey-Coquais, Christelle Ratignier-Carbonneil, Catherine Lassale, Rima De Sahb Berkovitch, Jean-Yves Fagon, Jean-Hugues Trouvin, Jean-Louis Prugnaud, Jean-Louis Montastruc, Nicole Casadevall, Didier Laloye, Philippe Lechat, Cécile Delval, François Gary, Marta Gersberg, Claire Le Jeunne, Corinne Blachier-Poisson, Danièle Girault
Publikováno v:
Therapies. 70:37-46
Resume Le medicament biosimilaire (BS) correspond a un medicament biologique declare comme similaire a un medicament biologique de reference et dont le plan de developpement inclut des etudes de comparaison par rapport a la reference, afin de confirm
Autor:
Roland Le Meur, Christelle Ratignier-Carbonneil, Philippe Burnel, Danièle Girault, Isabelle Giri, Faiez Zannad, Béatrice Falise-Mirat, Patrick Rossignol, Philippe Maugendre, Evelyne Satonnet, Laurent Treluyer, Jean-Marie Goehrs, Pierre Simon, Pierre Leurent, Catherine Lassale, Antoine Audry, Lucile Blaise, Carole Avril, Olivier Blin
Publikováno v:
Therapies. 69:339-346
Resume Le concept de telemedecine a ete officialise en France avec la loi hopital patients sante territoires (HPST) de 2009 et le decret d’application de 2010. De nombreuses experimentations ont ete mises en œuvre et les institutions de regulation
Autor:
Séverine Pitel, Emmanuel Teiger, Christelle Ratignier, Karine Szwarcenstein, Bernard Avouac, Odile Sechoy, Patricia Descamps-Mandine, Lucie Aubourg, Marcel Goldberg, Claire Coqueblin, François Parquin, Bernard Guillot, Serge Hanoka, Cédric Carbonneil, André Tanti, Karine Levesque, Nicolas Thevenet, Michel Cucherat, Anne Josseran
Publikováno v:
Therapies. 69:303-312
Resume Le dispositif medical se caracterise notamment par une grande heterogeneite (de l’abaisse langue a la prothese de hanche, en passant par le dispositif non implantable a invasif), un cycle de vie court des produits avec des innovations increm
Autor:
Danièle, Girault, Jean-Hugues, Trouvin, Corinne, Blachier-Poisson, François, Gary, Didier, Laloye, Jean-François, Bergmann, Nicole, Casadevall, Cécile, Delval, Rima, De Sahb Berkovitch, Jean-Yves, Fagon, Marta, Gersberg, Catherine, Lassale, Philippe, Lechat, Claire, Le Jeunne, Jean-Louis, Montastruc, Jean-Louis, Prugnaud, Christelle, Ratignier-Carbonneil, Cécile, Rey-Coquais
Publikováno v:
Therapie. 70(1)
A biosimilar is a biological medicinal product claimed to be similar to a reference biological medicinal product. Its development plan includes studies comparing it with the reference product in order to confirm its similarity in terms of quality, pr